Research Matters

Click here to view previous editions of Research Matters and Research News and Updates.




Latest News

Research Newsletter
January 20, 2015  

National Multiple Sclerosis Society

The Barancik Prize for Innovation in Multiple Sclerosis Research recognizes an exceptional scientist or a team of scientists whose work in MS research has demonstrated outstanding innovation and originality.

The prize is administered by the National Multiple Sclerosis Society. A selection committee comprised of leaders in science, medicine, and MS advocacy will review nominees. The committee will evaluate:
• Exceptional innovation and originality in scientific research relevant to MS
• Impact and potential of the research to lead to pathways for the treatment and cure for MS
• Scientific accomplishments that merit recognition as a future leader in MS research

For more information and guidelines , visit the Society’s website.

 

CDC: Economic Studies of Immunization Policies and Practices

Funding Opportunity Number: RFA-IP-15-001

The purpose of this Funding Opportunity Announcement is to obtain economic information about vaccines and immunization policies, programs, and practices using economic and decision analyses and other appropriate methods. The results of these economic studies will be used to help inform policy and the development of effective interventions. Three studies will be conducted, including an analysis of the financial, economic, and epidemiologic relationships between vaccine-preventable infectious diseases and chronic diseases in adult populations, and the opportunity costs for immunization of failure to prevent chronic diseases. Study 1 may include, but need not be limited to influenza and pneumococcal diseases and diabetes. Study 2 will focus on an estimation of the costs of norovirus disease. Study three will involve an analysis of issues related to provider reimbursement for adult vaccination services.

Application Deadline: March 3, 2015

For more information visit the CDC’s Full Funding Opportunity Announcement.

 
National Center for Accelerated Innovations (NCAI)

The Office of Translation and Innovation will host an information session on the National Center for Accelerated Innovations (NCAI) program, including details on the current RFA, led by Mark Low, Managing Director for the NCAI-Cleveland Clinic and Mark Chance, Vice Dean for Research in the CWRU School of Medicine.

The information session will be held next Monday, January 26 from 12n - 1pm in BRB 932.

All interested investigators are encouraged to attend. If you are coming from outside the School of Medicine, please stop by the security desk on the ground floor of the Biomedical Research Building and they will give you access to the elevators.

Drs. Low and Chance, among others, will be on hand to help answer any questions you have about this innovations program. The NCAI is currently running it's third funding cycle RFA. This regional funding opportunity is a great chance to move your translational research project to the next level.

Letter of Intent deadline is February 10, 2015

Please RSVP to Anne DeChant or to som-translation-innovation@case.edu

For more information on the RFA visit the NCAI-CC website.

 
NEW Limited Submission: NSF Collections in Support of Biological Research (CSBR)

Key Deadlines: March 23, 2015, 5:00pm (CWRU Internal Submission Deadline), July 13, 2015, 5:00pm EST(agency application).

The Collections in Support of Biological Research (CSBR) Program provides funds: 1) for improvements to secure, improve, and organize collections that are significant to the NSF BIO-funded research community; 2) to secure collections-related data for sustained, accurate, and efficient accessibility of the collection to the biological research community; and 3) to transfer collection ownership responsibilities.

The CSBR program provides for enhancements that secure and improve existing collections, result in accessible digitized specimen-related data, and develop better methods for specimen curation and collection management. Requests should demonstrate a clear and urgent need to secure the collection, and the proposed activities should address that need. Biological collections supported include established living stock/culture collections, vouchered non-living natural history collections, and jointly-curated ancillary collections such as preserved tissues and DNA libraries.

For more information on this limited submission opportunity, visit the Office of Research Administration website.

 
Ohio Third Frontier (OTF), Ohio Development Services Agency

The goal of the Ohio Third Frontier Technology Validation and Start-Up Fund (TVSF) is to increase economic growth in Ohio through start-up companies that commercialize technologies developed by Ohio institutions of higher education and other Ohio not-for-profit research institutions. Two separate mechanisms have been set up to achieve these goals:

Phase 1 –Technology Validation The specific objectives of this phase are as follows:
• To generate the proof needed to move technology to the point that it is either ready to be licensed by an Ohio start-up company or otherwise deemed unfeasible for commercialization.
• To fund validation activities, such as prototyping, demonstrations, and assessment of critical failure points in subsequent development, scale-up, and commercialization.

Phase 2 – Start-Up Funds The specific objectives of this phase are as follows:
• To support Ohio start-up companies that have licensed technology developed at Ohio research institutions during the critical early life of the company, and accelerate the time to market of this technology.
• To generate the proof needed to either commercialize the technology or move the technology to the point where additional funds needed for commercialization can be raised.
• To fund activities in order to generate the needed proof.

The TVSF will support technology that falls within the following areas: Advanced Materials related to advanced polymers, ceramics, composites, carbon fibers and nanotubes and specialty metals and alloys; Aeropropulsion Power Management; Agribusiness and Food Processing; Fuel Cells and Energy Storage; Medical Technology related to imaging, surgical instruments/equipment, implant devices, and regenerative medicine; Software Applications for business and healthcare; Sensing and Automation Technologies; Situational Awareness and Surveillance Systems; Solar Photovoltaics; and Shale.

Potential CWRU Applicants - Contact:
Michael Haag, MS, MBA, Executive Director, Technology Management, 216-368-6106 or mhaag@case.edu.

For more information on the TVSF visit the Ohio Third Frontier website.

 

If you have news or information that you wish to have included in this update, please send it via e-mail to Tracy Wilson-Holden at tracy.wilson-holden@case.edu no later than 5 pm on the Monday of the week that the update is to be distributed. If you know of individuals who may be interested in receiving this update, please forward this e-mail to them. To subscribe or unsubscribe to Case Research News, email your request to Tora Williams at tora.williams@case.edu.

Please note: At the time of this transmission, all links functioned. However, Case Research News cannot guarantee that the information will not move or be deleted.